相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma
Eudocia Q. Lee et al.
NEURO-ONCOLOGY (2015)
The Effects of Histone Deacetylase Inhibitors on Glioblastoma-Derived Stem Cells
Angel A. Alvarez et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2015)
Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial
Walter Taal et al.
LANCET ONCOLOGY (2014)
Histone Deacetylase Inhibitors: An Attractive Strategy for Cancer Therapy
Jiyang Li et al.
CURRENT MEDICINAL CHEMISTRY (2013)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2013)
Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade glioma
J. Drappatz et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme
R. Helseth et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Hypofractionated Stereotactic Radiation Therapy: An Effective Therapy for Recurrent High-Grade Gliomas
Shannon E. Fogh et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
Henry S. Friedman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
Teri N. Kreisl et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
In vivo efficacy of a novel histone deacetylase inhibitor in combination with radiatio or the treatment of gliomas
Michal Entin-Meer et al.
NEURO-ONCOLOGY (2007)
Histone deacetylase inhibitor and demethylating agent chromatin compaction and the radiation response by cancer cells
Gil Bar-Sela et al.
CANCER JOURNAL (2007)
The paradox of histone deacetylase inhibitor-mediated modulation of cellular responses to radiation
TC Karagiannis et al.
CELL CYCLE (2006)
Modulation of cellular radiation responses by histone deacetylase inhibitors
T. C. Karagiannis et al.
ONCOGENE (2006)
Radiation and new molecular agents, part II: Targeting HDAC, HSP90, IGF-1R, PI3K, and Ras
P Chinnaiyan et al.
SEMINARS IN RADIATION ONCOLOGY (2006)
Acetylation and deacetylation of non-histone proteins
MA Glozak et al.
GENE (2005)
Modulation of radiation response by histone deacetylase inhibition
P Chinnaiyan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Enhancement of xenograft tumor radiosensitivity by the histone deacetylase inhibitor MS-275 and correlation with histone hyperacetylation
K Camphausen et al.
CLINICAL CANCER RESEARCH (2004)
分享论文
